Products

What will AGI do for Aminophylline?

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula 2C7H8N4O2.C2H8N2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y7E0LU9ZMS. European Medicines Agency schedules aminophylline hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00461MIG. Most nations schedule aminophylline under HS 29395900 and SITC 54145. As of Q4 2014, AMINOPHYLLINE remains the US FDA Preferred Term for this commodity. Aminophylline bears US NLM identifiers UMLS ID C0002575 and NCI Concept Code C47393. SMILES: CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N.O.

How AGI delivers it

Four ways AGI delivers for Aminophylline

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aminophylline, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aminophylline, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aminophylline connects

measured by

  • Acidity (pH)model
  • Assay Puritymodel
  • Ethylenediamine Contentmodel
  • Loss On Dryingmodel
  • Theophylline Assaymodel
  • Theophylline Contentmodel